Untangling MS

Multiple sclerosis researchers have typically sought to dial down inflammation and reduce disease metrics that encompass a wide range of disabilities. A UCLA team is bucking those trends by identifying disease-modifying targets in specific brain cells to address distinct symptoms.

“Seeing patients with MS, it’s pretty clear that they differ with respect to which disability is bothering them the most,” such as difficulty walking, fatigue, cognitive dysfunction or vision problems, said Rhonda Voskuhl, professor of neurology at University of California Los Angeles (UCLA) and director of its MS program. ...